These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25389548)

  • 1. The vaginal microbiota and susceptibility to HIV.
    Buve A; Jespers V; Crucitti T; Fichorova RN
    AIDS; 2014 Oct; 28(16):2333-44. PubMed ID: 25389548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
    Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
    Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal microbiota and susceptibility to HIV.
    Eastment MC; McClelland RS
    AIDS; 2018 Mar; 32(6):687-698. PubMed ID: 29424773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases.
    Schwebke JR
    J Infect Dis; 2005 Oct; 192(8):1315-7. PubMed ID: 16170746
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV.
    Taha TE; Hoover DR; Dallabetta GA; Kumwenda NI; Mtimavalye LA; Yang LP; Liomba GN; Broadhead RL; Chiphangwi JD; Miotti PG
    AIDS; 1998 Sep; 12(13):1699-706. PubMed ID: 9764791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors.
    Chehoud C; Stieh DJ; Bailey AG; Laughlin AL; Allen SA; McCotter KL; Sherrill-Mix SA; Hope TJ; Bushman FD
    AIDS; 2017 Apr; 31(7):895-904. PubMed ID: 28121709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission.
    Armstrong E; Kaul R; Cohen CR
    J Intern Med; 2023 Apr; 293(4):433-444. PubMed ID: 36544257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
    van de Wijgert JH; Verwijs MC; Turner AN; Morrison CS
    AIDS; 2013 Aug; 27(13):2141-53. PubMed ID: 23660575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
    Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
    J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbiota and viral sexually transmitted diseases.
    Nardis C; Mosca L; Mastromarino P
    Ann Ig; 2013; 25(5):443-56. PubMed ID: 24048183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
    Vitali D; Wessels JM; Kaushic C
    AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate vaginal flora is associated with HIV prevalence as strongly as bacterial vaginosis in a cross-sectional study of participants screened for a randomised controlled trial.
    Guédou FA; Van Damme L; Mirembe F; Solomon S; Becker M; Deese J; Crucitti T; Alary M
    Sex Transm Infect; 2012 Nov; 88(7):545-51. PubMed ID: 22628663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium.
    Lokken EM; Balkus JE; Kiarie J; Hughes JP; Jaoko W; Totten PA; McClelland RS; Manhart LE
    Am J Epidemiol; 2017 Jul; 186(2):194-201. PubMed ID: 28472225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME.
    Marrazzo JM
    Trans Am Clin Climatol Assoc; 2018; 129():63-73. PubMed ID: 30166700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.
    Jespers V; van de Wijgert J; Cools P; Verhelst R; Verstraelen H; Delany-Moretlwe S; Mwaura M; Ndayisaba GF; Mandaliya K; Menten J; Hardy L; Crucitti T;
    BMC Infect Dis; 2015 Mar; 15():115. PubMed ID: 25879811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual networks, HIV, race and bacterial vaginosis.
    Kenyon C; Osbak K
    AIDS; 2015 Mar; 29(5):641-2. PubMed ID: 25710290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.